These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Pharmacokinetics and clinical studies on ceftriaxone in the field of obstetrics and gynecology]. Cho N; Watanabe H; Yoshida K; Moriyama S; Takeda H; Tsukamoto A; Fukunaga K; Kunii K; Komoriyama Y Jpn J Antibiot; 1984 Dec; 37(12):2304-19. PubMed ID: 6098723 [TBL] [Abstract][Full Text] [Related]
26. [Passage of ceftriaxone in the aqueous humor and tears. Comparison with other beta-lactams]. Mounier M; Denis F; Adenis JP Pathol Biol (Paris); 1984 May; 32(5):335-7. PubMed ID: 6330646 [TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics of SCE-1141, a stereoisomer of cefmenoxime, in rats. Kita Y; Itakura K; Tsuchiya K; Imada A J Antimicrob Chemother; 1986 Feb; 17(2):205-13. PubMed ID: 3457784 [TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetics of ceftriaxone in subjects with renal insufficiency. Kowalsky SF; Echols RM; Parker MA Clin Pharm; 1985; 4(2):177-81. PubMed ID: 3987216 [TBL] [Abstract][Full Text] [Related]
29. [Clinical study of a new cephalosporin, ceftriaxone (Rocefin Roche) in bronchopneumonia in children]. De Marco A; Manca B Ann Osp Maria Vittoria Torino; 1983; 26(1-6):91-6. PubMed ID: 6093666 [TBL] [Abstract][Full Text] [Related]
30. [Ceftriaxone-concentrations in heart tissue. Preliminary results]. Struck E; Adam D; Meisner H; Richter J; Sebening F Wien Med Wochenschr Suppl; 1985; 87():8-11. PubMed ID: 3856976 [No Abstract] [Full Text] [Related]
31. Single-dose ceftriaxone pharmacokinetics in pediatric patients with central nervous system infections. Chadwick EG; Yogev R; Shulman ST; Weinfeld RE; Patel IH J Pediatr; 1983 Jan; 102(1):134-7. PubMed ID: 6294263 [TBL] [Abstract][Full Text] [Related]
32. Single-dose ceftriaxone kinetics in the newborn. Schaad UB; Hayton WL; Stoeckel K Clin Pharmacol Ther; 1985 May; 37(5):522-8. PubMed ID: 3987175 [TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetics of a new cephalosporin, cefotaxime (HR 756) in patients with different renal functions. Bergan T; Larsen EW; Brodwall EK Chemotherapy; 1982; 28(2):85-104. PubMed ID: 6280931 [No Abstract] [Full Text] [Related]
34. A pharmacokinetic and tolerance study of Ro13-9904, a new cephalosporin antibiotic. Pickup ME; Bird HA; Lowe JR; Lees L; Wright V Br J Clin Pharmacol; 1981 Aug; 12(2):111-5. PubMed ID: 6272830 [TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics of ceftriaxone following intravenous administration of a 3 g dose. McNamara PJ; Stoeckel K; Ziegler WH Eur J Clin Pharmacol; 1982; 22(1):71-5. PubMed ID: 6284519 [TBL] [Abstract][Full Text] [Related]
36. Serum protein binding and extravascular diffusion of methoxyimino cephalosporins. Time courses of free and total concentrations of cefotaxime and ceftriaxone in serum and pleural exudate. Scaglione F; Raichi M; Fraschini F J Antimicrob Chemother; 1990 Sep; 26 Suppl A():1-10. PubMed ID: 2228838 [TBL] [Abstract][Full Text] [Related]
37. Volume of distribution terms for a drug (ceftriaxone) exhibiting concentration-dependent protein binding. II. Physiological significance. McNamara PJ; Gibaldi M; Stoeckel K Eur J Clin Pharmacol; 1983; 25(3):407-12. PubMed ID: 6313380 [TBL] [Abstract][Full Text] [Related]
38. Ceftriaxone: increasing the half-life and activity of third generation cephalosporins. Steele RW Pediatr Infect Dis; 1985; 4(2):188-91. PubMed ID: 3885182 [No Abstract] [Full Text] [Related]
39. Comparative pharmacokinetics of ceftriaxone after subcutaneous and intravenous administration. Borner K; Lode H; Hampel B; Pfeuffer M; Koeppe P Chemotherapy; 1985; 31(4):237-45. PubMed ID: 4028870 [TBL] [Abstract][Full Text] [Related]
40. [Level of evidence for therapeutic drug monitoring of ceftriaxone]. Dailly E; Verdier MC; Deslandes G; Bouquié R; Tribut O; Bentué-Ferrer D Therapie; 2012; 67(2):145-9. PubMed ID: 22850101 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]